Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prevalence of Glaucoma in the Israeli Arab Population

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Ziv Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Ziv Hospital Identifier:
First received: March 1, 2012
Last updated: March 6, 2012
Last verified: March 2012
there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.


Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Glaucoma Prevalence in the Israeli Arab Population

Resource links provided by NLM:

Further study details as provided by Ziv Hospital:

Estimated Enrollment: 15000
Study Start Date: January 2012
Estimated Study Completion Date: May 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Glaucoma patients
all the ,medical records of patients who were diagnosed with primary open angle glaucoma, closed angle , pseudoexfoliative and neovascular glaucoma.

Detailed Description:
from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinics from 1 Arab city in the center of Israel

Inclusion Criteria:

  • Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes
  • Intraocular pressure (IOP) > 23 mm Hg
  • Damage to the field of vision
  • Age- above 20 Yrs. old

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01546740

Contact: Joseph Pikkel, M.D +972508434206
Contact: Otzem Chassid, M.D +972506266059

Ziv Medical Center Recruiting
Safed, Israel, 13120
Contact: Joseph Pikkel, M.D    +972508434206   
Contact: Otzem Chassid, M.D    +972506266059   
Sponsors and Collaborators
Ziv Hospital
Principal Investigator: Joseph Pikkel, M.D Ziv Medical Center
  More Information

Responsible Party: Ziv Hospital Identifier: NCT01546740     History of Changes
Other Study ID Numbers: ZIV-0060-11 
Study First Received: March 1, 2012
Last Updated: March 6, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Ziv Hospital:
Glaucoma, Compliance, Prevalence

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases processed this record on October 21, 2016